首页> 外文期刊>Current pharmacogenomics and personalized medicine >The pharmacomicrobiomics portal: A database for drug-microbiome interactions
【24h】

The pharmacomicrobiomics portal: A database for drug-microbiome interactions

机译:药物微生物学门户网站:药物-微生物组相互作用的数据库

获取原文
获取原文并翻译 | 示例
       

摘要

The human microbiota directly and indirectly impacts drug pharmacokinetics and pharmacodynamics, thus affecting treatment outcome and subsequently human health. The Human Microbiome Project (HMP) revived interest in the role of human microbiota in health and disease. Yet, no repository of reported drug-microbe interactions is publicly available, and no attempts have been made to link those interactions to the human microbiome in a structured way. To begin addressing the need for such a crucial and timely resource, we analyzed published experimental data to extract drug-microbe interactions so as to enable the application of emerging HMP knowledge in postgenomics personalized medicine. We hereby report the creation of the PharmacoMicrobiomics Database, which aims to collect, classify, and cross-reference known drug-microbiome interactions and categorize them according to body site and microbial taxonomy. The database is integrated into a web portal that includes a search engine, through which students and scholars can locate drug-microbiome interaction of interest, compiled from and connected to public databases, such as PubMed, PubChem, and Comparative Toxicogenomics. Making these data available is a significant first step towards the prediction of interactions between drugs with similar chemical properties and microbes with similar metabolic abilities. Currently, the PharmacoMicrobiomics Database contains drug-microbiome interactions for more than 60 drugs curated from over 100 research and review articles. Further developments will include the automation of data updating, classification based on drug classes and biochemical pathways, and the participation of the community into data curation and analysis. This work provides a timely and much needed pioneering resource to the global open science community and usefully builds bridges between the rapidly growing fields of pharmacogenomics and human microbiome research. Database URL: http://www.pharmacomicrobiomics.org; Source Code: http://sourceforge.net/projects/pharmacomicro.
机译:人类微生物群直接和间接影响药物的药代动力学和药效学,从而影响治疗结果并进而影响人类健康。人类微生物组计划(HMP)重新引起了人们对人类微生物在健康和疾病中的作用的兴趣。但是,尚无公开报道的药物-微生物相互作用的资料库,也没有尝试以结构化的方式将这些相互作用与人类微生物组联系起来。为了开始满足对这种关键且及时的资源的需求,我们分析了已发表的实验数据以提取药物与微生物的相互作用,从而使新兴的HMP知识能够应用于后基因组学个性化医学中。我们在此报告PharmacoMicrobiomics数据库的创建,该数据库旨在收集,分类和交叉引用已知的药物-微生物组相互作用,并根据身体部位和微生物分类对它们进行分类。该数据库被集成到一个包含搜索引擎的网络门户中,学生和学者可以通过该门户找到感兴趣的药物-微生物组相互作用,该相互作用是从公共数据库(如PubMed,PubChem和比较毒理基因组学)编译并与之连接的。使这些数据可用是预测具有相似化学性质的药物与具有相似代谢能力的微生物之间相互作用的重要的第一步。目前,PharmacoMicrobiomics数据库包含来自100多个研究和评论文章的60多种药物的药物-微生物组相互作用。进一步的发展将包括数据更新的自动化,基于药物类别和生化途径的分类以及社区参与数据管理和分析。这项工作为全球开放科学界提供了及时且急需的开拓性资源,并在快速发展的药物基因组学领域与人类微生物组研究之间架起了桥梁。数据库网址:http://www.pharmacomicrobiomics.org;源代码:http://sourceforge.net/projects/pharmacomicro。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号